Benign neoplasm of mesothelial tissue
Chapter 2:Neoplasms
ICD-10 D19 is a billable code used to indicate a diagnosis of benign neoplasm of mesothelial tissue.
Benign neoplasms of mesothelial tissue, such as those arising from the pleura, peritoneum, or pericardium, are generally non-cancerous growths that can occur in various anatomical locations. These neoplasms may present as localized masses and are often asymptomatic, discovered incidentally during imaging studies or surgical procedures. While benign, they can sometimes cause symptoms due to mass effect, such as pain or respiratory distress, depending on their size and location. Surveillance is essential, as these neoplasms can occasionally exhibit atypical features that warrant further investigation. Although the malignant potential of benign mesothelial neoplasms is low, there is a need for careful monitoring to ensure that they do not transform into malignant forms, particularly in patients with a history of asbestos exposure or other risk factors. Regular follow-up imaging and clinical evaluations are recommended to assess for any changes in size or characteristics of the neoplasm.
Detailed pathology reports and imaging studies must be included to support the diagnosis.
Patients presenting with incidental findings on imaging or those undergoing surveillance for known benign neoplasms.
Oncologists should be aware of the potential for atypical features that may necessitate further evaluation.
Pulmonary function tests and imaging studies should be documented to assess any impact on respiratory function.
Patients with pleural masses presenting with respiratory symptoms or those with a history of asbestos exposure.
Pulmonologists must document any changes in symptoms or imaging findings to ensure appropriate follow-up.
Used when a pleural mass is suspected to be a neoplasm.
Pathology report confirming the benign nature of the neoplasm.
Pulmonologists should ensure thorough documentation of the biopsy findings.
Monitoring is crucial as benign mesothelial neoplasms can occasionally exhibit atypical features that may indicate a risk for malignant transformation, especially in patients with a history of exposure to carcinogens.
